4894 Cuorips
- 7150
- +150+2.14%
Cuorips News
Cuorips: Matters related to business plans and growth potential.
Cuorips: Announcements of individual stocks regarding the establishment of a subsidiary in USA.
Cuorips: Announcements of individual stocks: Change of application period using long-term data in clinical trials of iPS-derived myocardial cell sheets.
Cuorips: Independent Company Executives Declaration
Cuorips: Notice of provision of cardiomyocyte sheets for treatment of dilated heart disease using human iPS cell-derived cardiomyocyte sheets
Cuorips: About some reports about our company
Cuorips: Announcement of the launch of a cell mass manufacturing value chain consortium that enables the development and practical application of next-generation regenerative medicine modalities
Cuorips: Notice regarding changes in officers
Cuorips: Notice of commencement of joint development related to a cell mass manufacturing system based at Nakanoshima Qross
Cuorips: About Minister of Economy, Trade and Industry Nishimura's speech at the University of California, Berkeley, Haas School of Business
Cuorips: Announcement of the presentation at the AHA (American Heart Association) Scientific Session
Cuorips: Decision to move into the business site established by the Ministry of Economy, Trade and Industry in Silicon Valley, USA
Cuorips: Notice regarding establishment of a subsidiary
Cuorips: Notice Concerning the Recording of Non-Operating Expenses (Listing Related Expenses and Stock Grant Expenses)
Cuorips: Independent Officer Notification Form
Cuorips: Articles of Incorporation 2023/03/29
Cuorips: Notice regarding changes in other affiliated companies
Cuorips: Matters relating to business plans and growth potential
Cuorips: Notice of our financial results information etc. associated with listing on the Tokyo Stock Exchange Growth Market
Cuorips: (Additional) Revised securities report for listing application
Analysis
Price Target
No Data
